Greenwich LifeSciences (GLSI) released its quarterly earnings, reporting a loss of $0.27 per share. This result exceeded analyst expectations, suggesting a better-than-anticipated financial performance despite the net loss.
Greenwich LifeSciences Reports Q2 Earnings, Loss of $0.27 Per Share
Greenwich LifeSciencesearnings reportQ2 earningsbiotechnologyearnings beat



